Blood Pressure and Arteries STUDIES

Highlights Meta-analysis of 21 randomized, controlled trials Resveratrol significantly (P<.05) lowers total cholesterol, systolic blood pressure, and fasting glucose Subgroup analysis show significant reductions in total cholesterol, blood pressure, glucose,...

Highlights Meta-analysis of 5 randomized, controlled clinical trials involving 194 patients Subjects include patients with and without established cardiovascular disease CoQ10 dosages range from 150 to 300 mg/day; study durations from...

Highlights Meta-analysis of 7 randomized, controlled clinical trials Participants include people with CVD, diabetes and other diseases CoQ10 dosage range 60-300 mg/day, study duration 8 to 12 weeks CoQ10 reduces plasma levels...

Highlights Data extracted from 7 systematic reviews, describing 71 RCTs Interventions compared CoQ10 vs. placebo All systematic reviews in patients with heart failure included Findings suggest CoQ10 may offer clinical...

Highlights Randomized, double-blind, placebo-controlled, multi-center clinical trial Participants include 420 patients with moderate-to-severe chronic heart failure CoQ10, added to standard therapy, significantly reduces symptoms and major adverse cardiovascular events Effective...